Mammoth Biosciences Stock
Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Founded in 2017 by notable figures including Nobel laureate Jennifer Doudna, the company aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.
Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock
Buy + SellMammoth Biosciences Funding
Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Apr 22, 2024 | Series D | 106.69M | ||
| Aug 05, 2021 | Series D | 150.00M | ||
| May 19, 2020 | Series C | 49.25M | ||
| May 19, 2020 | Series C | 747.77K | ||
| Feb 24, 2020 | Series B | 36.77M | ||
| Feb 24, 2020 | Series B | 7.41M | ||
| Feb 25, 2019 | Series A | 4.94M | ||
| May 15, 2018 | Series A | 13.16M |
See Mammoth Biosciences Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Mammoth Biosciences Stock Valuation + Share Prices
View real-time Tape D™ data on Mammoth Biosciences stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Mammoth Biosciences Management Team
Co-Founder, CEO, Director
Trevor Martin
Director
Maneesh Jain
Co-founder, Chief Science Officer
Lucas Harrington
Co-founder, Chair of Scientific Advisory Board
Jennifer A. Doudna
Co-Founder, Chief Technology Officer, Director
Janice Chen
Director
Min Cui
Director
Jeff Huber
Director
Jeremy Green
Mammoth Biosciences Major Investors
Decheng Capital LLC
aMoon Fund
Plum Alley Co.
Pacific 8 Ventures
Greenspring Associates, Inc
Verily Life Sciences LLC
Foresite Capital
Sixth Street Partners
NFX
Redmile Group
Greenspring Associates, Inc
Senator Investment Group
8VC
Mayfield Fund
Learn More About Mammoth Biosciences Stock
Buy Mammoth Biosciences Stock
01Mammoth Biosciences stock does not trade on public stock exchanges. Mammoth Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Mammoth Biosciences stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Mammoth Biosciences Stock
02Mammoth Biosciences Stock does not trade on public stock exchanges. In order to sell Mammoth Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Mammoth Biosciences Stock Price
03Mammoth Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Mammoth Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
Mammoth Biosciences Stock Ticker Symbol
04There is no ticker symbol for Mammoth Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Mammoth Biosciences Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Mammoth Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Mammoth Biosciences Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Mammoth Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Mammoth Biosciences Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Mammoth Biosciences IPO
08Mammoth Biosciences is a private company and has not had an IPO. There is currently no Mammoth Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Mammoth Biosciences IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
